Stratos Wealth Partners, Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Stratos Wealth Partners, Ltd.

  • $6.79 Billion
  • Q3 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 779 shares of REGN stock, worth $584,421. This represents 0.01% of its overall portfolio holdings.

Number of Shares
779
Previous 671 16.1%
Holding current value
$584,421
Previous $705,000 16.03%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$1024.09 - $1201.76 $110,601 - $129,790
108 Added 16.1%
779 $818,000
Q2 2024

Jul 24, 2024
BUY
$883.2 - $1071.19 $40,627 - $49,274
46 Added 7.36%
671 $705,000
Q1 2024

Apr 16, 2024
BUY
$902.69 - $993.35 $182,343 - $200,656
202 Added 47.75%
625 $601,000
Q4 2023

Jan 24, 2024
SELL
$775.18 - $881.7 $33,332 - $37,913
-43 Reduced 9.23%
423 $371,000
Q3 2023

Oct 24, 2023
BUY
$692.45 - $844.37 $73,399 - $89,503
106 Added 29.44%
466 $383,000
Q2 2023

Jul 18, 2023
BUY
$700.03 - $830.35 $30,101 - $35,705
43 Added 13.56%
360 $258,000
Q1 2023

Apr 27, 2023
BUY
$680.49 - $826.97 $24,497 - $29,770
36 Added 12.81%
317 $260,000
Q4 2022

Jan 19, 2023
SELL
$705.89 - $766.39 $9,176 - $9,963
-13 Reduced 4.42%
281 $0
Q3 2022

Oct 24, 2022
BUY
$573.97 - $724.32 $168,747 - $212,950
294 New
294 $203,000
Q2 2022

Jul 22, 2022
SELL
$548.35 - $738.84 $293,367 - $395,279
-535 Closed
0 $0
Q1 2022

Apr 26, 2022
BUY
$595.12 - $698.43 $9,521 - $11,174
16 Added 3.08%
535 $374,000
Q4 2021

Jan 14, 2022
SELL
$543.48 - $670.97 $125,543 - $154,994
-231 Reduced 30.8%
519 $328,000
Q3 2021

Oct 19, 2021
BUY
$574.03 - $680.96 $430,522 - $510,720
750 New
750 $454,000
Q3 2020

Oct 29, 2020
SELL
$544.75 - $658.21 $332,297 - $401,508
-610 Closed
0 $0
Q2 2020

Jul 28, 2020
BUY
$493.32 - $643.92 $300,925 - $392,791
610 New
610 $380,000
Q4 2018

Feb 08, 2019
SELL
$335.82 - $403.04 $10,410 - $12,494
-31 Closed
0 $0
Q3 2018

Nov 02, 2018
BUY
$351.14 - $408.51 $10,885 - $12,663
31 New
31 $13,000
Q2 2018

Aug 13, 2018
SELL
$284.6 - $344.99 $4,838 - $5,864
-17 Closed
0 $0
Q1 2018

May 10, 2018
SELL
$315.82 - $393.78 $3,474 - $4,331
-11 Reduced 39.29%
17 $6,000
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $10,041 - $13,158
28
28 $11,000

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email